Literature DB >> 31385085

Pediatric craniopharyngioma.

Annie Drapeau1,2, Patrick C Walz3,4, Jacob G Eide5, Alex J Rugino6, Ammar Shaikhouni1,2, Ahmed Mohyeldin2, Ricardo L Carrau2,7, Daniel M Prevedello1,2,7.   

Abstract

BACKGROUND: Craniopharyngioma has historically been recognized to be a formidable pathology primarily due to its proximity to critical neurovascular structures and the challenging surgical corridors that surgeons have tried to reach this lesion. FOCUS OF REVIEW: In this work, we review the medical and surgical management of these tumors with a focus on clinical presentation, diagnostic identification, surgical approach, and associated adjuvant therapies. We will also discuss our current treatment paradigm using endoscopic, open, and combined approaches to craniopharyngiomas. The management of craniopharyngiomas requires a multidisciplinary team of surgeons, endocrinologists, and neuroanesthesiologists as well as neurocritical care specialists to deliver the most comprehensive and safest surgical resection with minimal postoperative morbidity.

Entities:  

Keywords:  Craniopharyngioma; Endonasal; Pediatric; Skull base

Year:  2019        PMID: 31385085     DOI: 10.1007/s00381-019-04300-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  9 in total

1.  Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study.

Authors:  Brandon M Lehrich; Khodayar Goshtasbi; Frank P K Hsu; Edward C Kuan
Journal:  Childs Nerv Syst       Date:  2021-02-28       Impact factor: 1.475

Review 2.  Dealing With Brain MRI Findings in Pediatric Patients With Endocrinological Conditions: Less Is More?

Authors:  Francesco Baldo; Maura Marin; Flora Maria Murru; Egidio Barbi; Gianluca Tornese
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

3.  A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.

Authors:  Feng Yuan; Xiangming Cai; Junhao Zhu; Lei Yuan; Yingshuai Wang; Chao Tang; Zixiang Cong; Chiyuan Ma
Journal:  Front Neurol       Date:  2021-12-13       Impact factor: 4.003

4.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

5.  Parafoveal and peripapillary vessel density in pediatric and juvenile craniopharyngioma patients.

Authors:  Ga-In Lee; Yikyung Kim; Kyung-Ah Park; Sei Yeul Oh; Doo-Sik Kong; Sang Duk Hong
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

Review 6.  Supratentorial Pediatric Midline Tumors and Tumor-like Lesions: Clinical Spectrum, Natural History and Treatment Options.

Authors:  Luca Paun; Alexandre Lavé; Gildas Patet; Andrea Bartoli
Journal:  Children (Basel)       Date:  2022-04-09

Review 7.  The expanded endonasal approach in pediatric skull base surgery: A review.

Authors:  Nyall R London; Gustavo G Rangel; Patrick C Walz
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-03-04

Review 8.  Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.

Authors:  Margaret C S Boguszewski; Adriane A Cardoso-Demartini; Cesar Luiz Boguszewski; Wassim Chemaitilly; Claire E Higham; Gudmundur Johannsson; Kevin C J Yuen
Journal:  Pituitary       Date:  2021-07-25       Impact factor: 4.107

9.  Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.

Authors:  Selveta S van Santen; Peter Wolf; Natalia Kremenevski; Cesar L Boguszewski; Hannes Beiglböck; Marta Fiocco; Mark Wijnen; Ville R Wallenius; Marry M van den Heuvel-Eibrink; Aart J van der Lely; Gudmundur Johannsson; Anton Luger; Michael Krebs; Michael Buchfelder; Patric J D Delhanty; Sebastian J C M M Neggers; Daniel S Olsson
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.